This might be due to the difference in mutation profiles in our study in which BAK NRASQ61K/BRAFWT primary human melanoma cells were used rather than the long-term culture M14 melanoma cells harboring a NRASWT/BRAFV600E mutation profile in the previous study. This evidence concerns the gene BAK1 and melanoma.